We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+3.63%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$4.45B
AUM Growth
+$192M
(+4.5%)
Cap. Flow
+$96.4M
Cap. Flow
% of AUM
2.17%
Top 10 Holdings %
Top 10 Hldgs %
37.03%
Holding
3,677
New
275
Increased
1,530
Reduced
993
Closed
158
Avg Time Held Equity + Options
4.4
years
Top 10 Avg Time Held Equity + Options
2.4
years
Top 20 Avg Time Held Equity + Options
3.6
years
Avg Time Held Equity only
4.4
years
Top 10 Avg Time Held Equity only
2.4
years
Top 20 Avg Time Held Equity only
3.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crown Castle
CCI
|
+$18.7M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$15.5M |
| 3 |
PIMCO Ultra Short Government Active ETF
BILZ
|
+$6.8M |
| 4 |
JPMorgan Active Bond ETF
JBND
|
+$5.14M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$5.06M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 3-12 Month T-Bill ETF
BILS
|
+$8.95M |
| 2 |
Palantir
PLTR
|
+$7.81M |
| 3 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$5.25M |
| 4 |
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
|
+$3.68M |
| 5 |
UnitedHealth
UNH
|
+$1.19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.71% |
| 2 | Technology | 16.97% |
| 3 | Healthcare | 8.95% |
| 4 | Financials | 7.08% |
| 5 | Communication Services | 5.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2901
Tarsus Pharmaceuticals
TARS
$3.22B
| $2.33K | ﹤0.01% |
+42
| New | +$1.91K |
2024 Q4
0 quarters
|
|
2902
American Assets Trust
AAT
$1.3B
| $2.31K | ﹤0.01% |
88
-16
| -15% | -$437 |
2020 Q2
18 quarters
|
|
2903
Novanta
NOVT
$4.96B
| $2.29K | ﹤0.01% |
15
-2
| -12% | -$339 |
2021 Q3
13 quarters
|
|
2904
Adtran
ADTN
$518M
| $2.29K | ﹤0.01% |
275
+47
| +21% | +$347 |
2023 Q1
7 quarters
|
|
2905
Pulmonx
LUNG
$76M
| $2.28K | ﹤0.01% |
336
| – | – |
2021 Q2
14 quarters
|
|
2906
Fortrea Holdings
FTRE
$2.11B
| $2.27K | ﹤0.01% |
122
-310
| -72% | -$6.04K |
2023 Q3
5 quarters
|
|
2907
DELISTED
Theravance Biopharma
TBPH
| $2.26K | ﹤0.01% |
+240
| New | +$2.18K |
2024 Q4
0 quarters
|
|
2908
SelectQuote
SLQT
$58.5M
| $2.23K | ﹤0.01% |
600
| – | – |
2024 Q1
3 quarters
|
|
2909
DELISTED
The Shyft Group
SHYF
| $2.23K | ﹤0.01% |
190
| – | – |
2024 Q3
1 quarter
|
|
2910
Abeona Therapeutics
ABEO
$253M
| $2.23K | ﹤0.01% |
400
| – | – |
2022 Q1
11 quarters
|
|
2911
LSI Industries
LYTS
$752M
| $2.21K | ﹤0.01% |
114
+98
| +613% | +$1.82K |
2024 Q3
1 quarter
|
|
2912
WisdomTree Floating Rate Treasury Fund
USFR
$20.8B
| $2.21K | ﹤0.01% |
44
| – | – |
2022 Q2
10 quarters
|
|
2913
Astrana Health
ASTH
$1.84B
| $2.21K | ﹤0.01% |
70
+46
| +192% | +$2.19K |
2024 Q2
2 quarters
|
|
2914
Hims & Hers Health
HIMS
$6.62B
| $2.2K | ﹤0.01% |
91
+24
| +36% | +$595 |
2024 Q2
2 quarters
|
|
2915
Dine Brands
DIN
$407M
| $2.2K | ﹤0.01% |
73
-579
| -89% | -$18.6K |
2023 Q2
6 quarters
|
|
2916
Crescent Energy
CRGY
$5.59B
| $2.19K | ﹤0.01% |
150
| – | – |
2023 Q1
7 quarters
|
|
2917
MetroCity Bankshares
MCBS
$1.01B
| $2.18K | ﹤0.01% |
68
+27
| +66% | +$874 |
2024 Q3
1 quarter
|
|
2918
Viavi Solutions
VIAV
$8.42B
| $2.18K | ﹤0.01% |
216
| – | – |
2018 Q4
24 quarters
|
|
2919
DELISTED
Assertio
ASRT
| $2.17K | ﹤0.01% |
166
| – | – |
2023 Q3
5 quarters
|
|
2920
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.87B
| $2.16K | ﹤0.01% |
13
| – | – |
2023 Q3
5 quarters
|
|
2921
Solaris Energy Infrastructure
SEI
$4.17B
| $2.16K | ﹤0.01% |
75
| – | – |
2024 Q3
1 quarter
|
|
2922
LXP Industrial Trust
LXP
$3.6B
| $2.15K | ﹤0.01% |
53
+46
| +657% | +$2.13K |
2024 Q3
1 quarter
|
|
2923
Recursion Pharmaceuticals
RXRX
$1.91B
| $2.15K | ﹤0.01% |
318
+156
| +96% | +$1.05K |
2023 Q2
6 quarters
|
|
2924
Hain Celestial
HAIN
$21.9M
| $2.15K | ﹤0.01% |
349
| – | – |
2019 Q2
22 quarters
|
|
2925
MillerKnoll
MLKN
$1.45B
| $2.15K | ﹤0.01% |
95
| – | – |
2016 Q4
32 quarters
|
|
Similar funds
Parallel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Parallel Advisors held 3,677 positions worth $4.45B, up 4.5% from $4.25B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Parallel Advisors's Q4 2024 filing shows 275 new, 1,530 increased, 993 reduced and 158 closed positions. Its largest new stake was PIMCO Ultra Short Government Active ETF: 67,253 shares worth $6.78M. The largest sale was State Street SPDR Bloomberg 3-12 Month T-Bill ETF, an estimated $8.95M.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 48% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q4 2024 buy was PIMCO Ultra Short Government Active ETF: 67,253 shares worth $6.78M.
- Parallel Advisors added most to Crown Castle in Q4 2024, an estimated $18.7M increase.
- Parallel Advisors's biggest Q4 2024 reduction was State Street SPDR Bloomberg 3-12 Month T-Bill ETF, cutting an estimated $8.95M.
- Parallel Advisors fully exited iShares iBonds Dec 2024 Term Corporate ETF in Q4 2024, selling an estimated $3.68M.
- Parallel Advisors's ten largest holdings make up 37% of its $4.45B portfolio in Q4 2024.
- Parallel Advisors opened 275 new positions and closed 158 in Q4 2024.
- Parallel Advisors's portfolio value rose 4.5% quarter-over-quarter to $4.45B.
Based on Parallel Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.